Answers are grounded in this paper and cite their sources.
The 24-week risk of Covid-19 outcomes was low after vaccination with mRNA-1273 or BNT162b2, although risks were lower with mRNA-1273 than with BNT162b2. This pattern was consistent across periods marked by alpha- and delta-variant predominance. (Funded by the Department of Veterans Affairs and others.).
No takes yet. Share an insight, caveat, or question.
Dickerman et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: